Hydrocodone: uses, dosing, side effects & brands

The label's Boxed Warning addresses alcohol directly: concomitant use of this opioid with benzodiazepines or other CNS depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. The Drug Interactions and Drug Abuse sections repeat that because the effect is additive (both depress the CNS), combining hydrocodone with alcohol raises the risk of hypotension, respiratory depression, and fatal overdose. This is an additive CNS/respiratory-depression warning, not a disulfiram-type reaction. This is what hydrocodone's FDA label says; alcohol advice depends on your dose and health, so confirm with your pharmacist.

The label states that physical dependence develops with continued use and that abrupt discontinuation or a significant dose reduction produces withdrawal signs and symptoms. It directs that the drug not be abruptly discontinued in a physically dependent patient; instead the prescriber gradually tapers the dose using a patient-specific plan based on the dose taken, duration of treatment, and the patient's attributes, since rapid tapering can cause serious withdrawal symptoms, uncontrolled pain, and suicide. The Boxed Warning separately describes Neonatal Opioid Withdrawal Syndrome (NOWS): prolonged opioid use in a pregnant woman can cause a potentially life-threatening withdrawal syndrome in the newborn that must be recognized and treated by neonatology experts. Do not stop hydrocodone on your own — any change is a prescriber-managed decision.

The elimination half-life of hydrocodone is about 3.8 hours (3.8 ± 0.3 hours) — that is how long the body takes to clear half of a dose. Hydrocodone is converted by the liver (via CYP2D6) to an active metabolite, hydromorphone; this metabolic step is well established even though this particular label's pharmacokinetics section does not name hydromorphone. The 3.8-hour value comes from a small study (five adult male subjects); clearance and half-life can be prolonged in people with impaired liver or kidney function, in older adults, and can vary with CYP2D6 metabolizer status. Half-life is not the same as how long a drug test can detect the drug, and it varies with age, kidney and liver function.

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run hydrocodone against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

Across the brands we track, hydrocodone is currently marketed as tablet, extended release, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

We do not currently list a generic-labelled hydrocodone product. That does not always mean none exists — it means none appears under a generic name in the FDA data we track. Ask your pharmacist.

Alcohol: the FDA label says to avoid alcohol — see the alcohol section above for what it actually says. This is what the FDA label and our cited sources say — it is not a complete list. Your pharmacist can check your own combination.

"In your system" means two different things. First is how long the drug is chemically active and clearing: hydrocodone's elimination half-life is about 3.8 to 4 hours for the immediate-release form found in Vicodin and Norco (FDA NORCO label reports 3.8 ± 0.3 hours; StatPearls reports approximately 4 hours). Because a drug is largely eliminated after roughly 4 to 5 half-lives, hydrocodone itself is mostly cleared from the bloodstream within about 16 to 24 hours in a person with normal liver and kidney function. Second is how long a drug test can still DETECT it or its metabolites (norhydrocodone, an inactive metabolite, and hydromorphone, an active one) — this is longer than the clearance time and varies by test type, from about a day in blood up to about 90 days in hair (that hair figure is a general hair-testing convention applied to opioids, not a hydrocodone-specific measured value, and is not addressed by the sources cited below). The ranges below are approximate; only a clinician or testing lab can interpret a specific result.

Urine is the most common test. In a controlled single-dose study (two 10 mg Norco tablets in healthy volunteers), hydrocodone was detectable in urine for about 25 to 26 hours (mean ~25.5 h in the study) — about a day — using a sensitive 50 ng/mL cutoff, and for under 5 hours at a higher 2000 ng/mL cutoff; the inactive metabolite norhydrocodone persisted somewhat longer but still under about 40 hours (SAMHSA/Flegel controlled-dose study). Detection windows run longer with repeated or high-dose use, and figures reported across general clinical references vary because labs use different cutoffs, assays, and study populations — sources genuinely differ, so treat any single number as approximate. The exact window depends on dose, how long and how often it was used, individual metabolism, hydration, and the specific assay's cutoff. An important, honest point: hydrocodone is a semi-synthetic opioid, and many older "opiate" immunoassay screens are calibrated to morphine and codeine and can under-detect or miss hydrocodone, so labs often confirm with a specific opioid panel or GC/MS or LC-MS/MS testing. Ranges are approximate; only a clinician or testing lab can interpret a specific result. This is not advice about how to alter a test result.

By test type: blood — the shortest window, up to about 24 hours, consistent with the roughly 4-hour half-life and with the controlled study in which blood levels fell off over the first day (SAMHSA/Flegel); saliva (oral fluid) — roughly 12 to 48 hours, within the same controlled study's oral-fluid collection window, with the exact figure varying by cutoff; and hair — hair testing is not addressed by the three sources cited below, but the standard hair-test window applied to opioids generally is up to about 90 days (roughly 3 months), reflecting hair growth rather than active drug levels. That 90-day figure is a general hair-testing convention, not a measured hydrocodone-specific value. These are approximate ranges that shift with dose, frequency of use, and individual factors, and only a clinician or testing lab can interpret a specific result.

Several factors change both clearance and detection time. Dose and frequency matter most: a single low dose clears faster than chronic or high-dose use, which can accumulate the drug and its metabolites. Metabolism varies with age, genetics, and especially liver and kidney function — hydrocodone is metabolized in the liver by the CYP3A4 enzyme (to inactive norhydrocodone) and CYP2D6 (to active hydromorphone) and eliminated mainly through the kidneys, so impaired organ function or interacting medications can lengthen the window. Body composition and hydration also play a role, as does the specific test used and its cutoff threshold — a more sensitive assay detects lower amounts for longer, which is why published windows vary between labs. Because of this variability, published windows are approximate ranges, not guarantees; only a clinician or testing lab can interpret an individual result.